Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system
about
EndothelinTGF-beta signal transduction and mesangial cell fibrogenesisPhysiological antagonism of endothelin-1 in human conductance and resistance coronary arteryImmunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular functionExercise limits the production of endothelin in the coronary vasculatureComparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.Vascular actions of insulin with implications for endothelial dysfunction.Peripheral circulation.Conceptual approaches for treatment of phosgene inhalation-induced lung injury.The effect of ozone on blood pressure in DOCA-salt-induced hypertensive rats.HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase.Cocaine- and amphetamine-regulated transcript (CART) peptide: a vasoactive role in the cerebral circulation.Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine.Nitric oxide modulation of ET(B) receptor-induced vasopressin release by rat and mouse hypothalamo-neurohypophyseal explants.PHARMACOLOGICAL REGULATION OF OUTFLOW RESISTANCE DISTAL TO SCHLEMM'S CANAL.
P2860
Q26767156-22716B61-5F2B-4BBF-AB9E-6389870A4D03Q28203185-837828BD-65B9-4AFA-A9C6-F18C9979686AQ28366585-CDFBB8FB-DE0F-4BC3-8D0E-FE27A7A66E6EQ34538722-BC83054C-D54B-460D-A869-794B08893E9CQ34979822-26ADC0F2-4C41-4466-BD62-F43365E5A432Q35044504-E57A676C-A76E-4D4C-9E29-D17820C2FFE0Q35047772-05E557BC-B1CF-4EE8-83DD-8E76D648F5F2Q37505788-F49CC814-9216-400A-BE31-39EFB7A8DAE1Q38111280-896FBD25-BABC-4C66-A0F9-7F16C073F46FQ38420382-8181FCA0-C7CB-4847-96E8-D2051151C8DCQ42124760-6F4525E3-581F-433D-A41D-9776AFC4A946Q43755565-1458A529-FDB5-4B0A-A3C2-2FB85BEFC508Q44705873-D0F8762C-D340-4765-805C-1A0731B4CB93Q46473024-1C6E1F32-CB77-4C08-BD02-5C3E12DC6DB5Q46635652-84900C83-B8FF-4F3D-AEE4-31ACEBFEB66FQ46853117-2DD63A8B-9649-46F2-8F83-8AACC899BD78Q52598356-11ED59FF-6A11-4AE6-BA06-584F899915C9
P2860
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nitric oxide-mediated modulati ...... he human cardiovascular system
@ast
Nitric oxide-mediated modulati ...... he human cardiovascular system
@en
Nitric oxide-mediated modulati ...... he human cardiovascular system
@nl
type
label
Nitric oxide-mediated modulati ...... he human cardiovascular system
@ast
Nitric oxide-mediated modulati ...... he human cardiovascular system
@en
Nitric oxide-mediated modulati ...... he human cardiovascular system
@nl
prefLabel
Nitric oxide-mediated modulati ...... he human cardiovascular system
@ast
Nitric oxide-mediated modulati ...... he human cardiovascular system
@en
Nitric oxide-mediated modulati ...... he human cardiovascular system
@nl
P2860
P3181
P356
P1476
Nitric oxide-mediated modulati ...... he human cardiovascular system
@en
P2093
A P Davenport
P2860
P304
P3181
P356
10.1038/SJ.BJP.0703834
P407
P577
2001-01-01T00:00:00Z